CEO & Director
Mr. Hendrick spent over 20 years working for Genzyme Corporation, most recently as the Vice President and General Manager of Early Development for the Oncology business. He has served as an advisor to Cetya since August, 2013, and as its CEO and a member of its Board of Directors since July, 2014...
Mr. Adair has over twenty five years pharmaceutical and medical device finance and operations experience including senior roles at Amgen, Thermo Fisher Scientific and Akzo Nobel NV. Mr. Adair is a CPA (Colorado) and holds an M.S. in Finance from the University of Colorado.
VP Operations & Pre-clinical Development
Dr. Junker has worked over 25 years developing and commercializing therapeutic products for biotechnology and drug companies. He has served as an advisor to Cetya since March, 2013 and its VP Operations and Preclinical Development since July, 2014...